金沙娱城手机app下载

Improve patients' lives by timely providing them with

quality and affordable protein therapeutics

Honor
  • 2019
    Global Generics & Biosimilars Awards 2019 "Biosimilar Initiative of the Year - 汉利康®"
  • 2019
    Equal Ocean "China Healthcare Industry Award – the Best Innovative Biopharmaceutical Enterprise"
  • 2019
    China Financial Market "Excellent Biopharmaceutical Enterprise" 
  • 2019
    Forbes China "The Most Innovative Companies in China"
  • 2019
    JRJ.com "Future Company of BioPharm Industry"
  • 2019
    Shanghai Worker Pioneer HLX01 Core Project Team
  • 2018
    Sina Medical "The Most Innovative Enterprise in Pharmaceutical Industry in 2018 China"
  • 2018
    Social Responsibility Conference "2018 Branding Award"
  • 2018
    Chinese Pharmaceutical Association "The Fast-growing Pharmaceutical Enterprise of Science and Technology Innovation in 2018"
  • 2018

    Ernst & Young "the Most Promising Enterprises in China"

  • 2018
     Vcbeat Net "Top of 2018 Future Medicine 100"
  • 2018

    Venture 50 "China Top 50 Investments for Value "

  • 2018

    China Business Journal "The Most Innovative Enterprise in Health Industry"

  • 2018

    The 7th China Finance Summit "The Most Innovative Enterprise"

  • 2018
    China Entrepreneur "Future Stars"
  • 2018

    Science and Technology Innovation Award for Songjiang Manufacturing Facility

  • 2018

    China Healthcare Consulting Group(CHC)-CITIC Securities "2017 Top Venture in Medical and Health"

  • 2018

    Life Science & Healthcare Unicorn Enterprise in Pudong New Area, Shanghai

  • 2018

    Innovative Startup Top 20 in Pudong New Area

  • 2018

    Haoyue Capital "Annual Best Venture Case in Biopharm "

  • 2018

    IMAPAC "Bioprocessing Innovations in Single-use Manufacturing in China"

  • 2018

    BioPharma "Asia Biotech of 2017"

  • 2017
    Life Science & Healthcare Unicorn Enterprise in China
  • 2017

    Deloitte Touche Tohmatsu " 2017 Future Star in the China Pharma Industry"

  • 2017

    IMAPAC "Leading Innovations in Cutting-edge Technologies for Novel mAb Development & Production"

  • 2017

    IMAPAC "Best Bioprocessing Excellence in China"

  • 2017

    Specialized & Innovative SME

  • 2016

    Hign and New Technology Enterprises

Global Generics & Biosimilars Awards 2019
"Biosimilar Initiative of the Year - 汉利康®"

Generics Bulletin & IQVIA


The Most Innovative Companies in China

Forbes China

Asia Biotech of 2017

BioPharma

Bioprocessing Innovations in Single-use Manufacturing in China
Development & Production

IMAPAC

Excellent Biopharmaceutical Enterprise

China Financial Market

Subsidies for Research Projects
  • 2011

    National Major New Drug Research & Development in the 12th Five-year Plan

  • 2012

    National Major New Drug Research & Development in the 12th Five-year Plan

  • 2015
    Shanghai Industry Transformation and Upgrade Program (Biopharmaceutical Commercial-scale Facility)
  • 2018

    Shanghai Industry Transformation and Upgrade Program (Projects to Build a Robust Foundation for Industrial Development)

  • 2018

    Technology Giant Enterprise

  • 2018

    National Major New Drug Research & Development in the 13th Five-year Plan

Baidu
sogou